[go: up one dir, main page]

DK0880524T3 - Adenosine antagonists, processes for their preparation and their use as drugs - Google Patents

Adenosine antagonists, processes for their preparation and their use as drugs

Info

Publication number
DK0880524T3
DK0880524T3 DK97933683T DK97933683T DK0880524T3 DK 0880524 T3 DK0880524 T3 DK 0880524T3 DK 97933683 T DK97933683 T DK 97933683T DK 97933683 T DK97933683 T DK 97933683T DK 0880524 T3 DK0880524 T3 DK 0880524T3
Authority
DK
Denmark
Prior art keywords
drugs
processes
preparation
adenosine antagonists
adenosine
Prior art date
Application number
DK97933683T
Other languages
Danish (da)
Inventor
Ulrike Kuefner-Muehl
Werner Kummer
Gerald Pohl
Wolfram Gaida
Erich Lehr
Joachim Mierau
Thomas Weiser
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Priority claimed from CA002242097A external-priority patent/CA2242097C/en
Application granted granted Critical
Publication of DK0880524T3 publication Critical patent/DK0880524T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK97933683T 1996-07-20 1997-07-17 Adenosine antagonists, processes for their preparation and their use as drugs DK0880524T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629378A DE19629378A1 (en) 1996-07-20 1996-07-20 New triazolopurines, process for their preparation and their use as medicaments
PCT/EP1997/003841 WO1998003511A1 (en) 1996-07-20 1997-07-17 New triazolopurines, method of preparing them and their use as drugs
CA002242097A CA2242097C (en) 1996-07-20 1998-06-26 Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK0880524T3 true DK0880524T3 (en) 2000-07-17

Family

ID=32963000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97933683T DK0880524T3 (en) 1996-07-20 1997-07-17 Adenosine antagonists, processes for their preparation and their use as drugs

Country Status (25)

Country Link
EP (2) EP0880524B1 (en)
JP (1) JP3020281B2 (en)
CN (1) CN1219936A (en)
AT (1) ATE191913T1 (en)
AU (1) AU3695597A (en)
BG (1) BG102707A (en)
BR (1) BR9710747A (en)
CA (1) CA2256736A1 (en)
CZ (1) CZ265498A3 (en)
DE (2) DE19629378A1 (en)
DK (1) DK0880524T3 (en)
EE (1) EE9800451A (en)
ES (1) ES2147453T3 (en)
GR (1) GR3033842T3 (en)
HR (1) HRP970395A2 (en)
HU (1) HUP9902311A3 (en)
ID (1) ID19106A (en)
IL (1) IL126453A0 (en)
NO (1) NO983860L (en)
PL (1) PL328824A1 (en)
PT (1) PT880524E (en)
SK (1) SK114498A3 (en)
TR (1) TR199801659T2 (en)
WO (1) WO1998003511A1 (en)
ZA (1) ZA976331B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826843A1 (en) * 1998-06-16 1999-12-23 Boehringer Ingelheim Pharma Novel imidazotriazolopyrimidines, process for their preparation and their use as medicaments
US6492377B1 (en) 1998-06-25 2002-12-10 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines with adenosine-antagonistic activity
AU9347498A (en) * 1998-08-27 2000-03-21 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines
US7329668B2 (en) 2003-02-25 2008-02-12 Bristol-Myers Squibb Company Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
US7071333B2 (en) 2003-07-30 2006-07-04 Bristol-Myers Squibb Company Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
AR061625A1 (en) * 2006-06-23 2008-09-10 Incyte Corp DERIVATIVES OF PURINONA AS AGONISTS OF HM74A
CR20230030A (en) 2018-02-27 2023-03-10 Incyte Corp Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
MX2020012376A (en) 2018-05-18 2021-03-09 Incyte Corp Fused pyrimidine derivatives as a2a / a2b inhibitors.
MX2021000116A (en) 2018-07-05 2021-03-29 Incyte Corp Fused pyrazine derivatives as a2a / a2b inhibitors.
PE20211768A1 (en) 2018-11-30 2021-09-07 Merck Sharp & Dohme DERIVATIVES OF AMINE TRIAZOLO QUINAZOLINE 9-SUBSTITUTED AS ANTAGONISTS OF THE ADENOSINE RECEPTOR, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
TWI829857B (en) 2019-01-29 2024-01-21 美商英塞特公司 Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors
CN112778311B (en) * 2019-11-01 2024-06-04 上海翰森生物医药科技有限公司 Nitrogen-containing cyclic derivative inhibitor, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA902282B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor compounds
IT1264901B1 (en) * 1993-06-29 1996-10-17 Schering Plough S P A HETEROCYCLIC ANALOGUES OF 1,2,4-TRIAZOLE(15-C)PYRIMIDINES WITH ANTAGONIST ACTIVITY FOR THE ADENOSINE A2 RECEPTOR
JPH083169A (en) * 1994-06-15 1996-01-09 Yamasa Shoyu Co Ltd 4-methyl-1h-(1,2,4)triazolo(1,5-a)purin-9(4h)-ones

Also Published As

Publication number Publication date
PT880524E (en) 2000-07-31
HUP9902311A3 (en) 2000-06-28
CN1219936A (en) 1999-06-16
CA2256736A1 (en) 1998-01-29
EP0978517A3 (en) 2003-11-12
IL126453A0 (en) 1999-08-17
DE59701467D1 (en) 2000-05-25
ES2147453T3 (en) 2000-09-01
HUP9902311A2 (en) 1999-10-28
TR199801659T2 (en) 1998-12-21
ATE191913T1 (en) 2000-05-15
EP0880524A1 (en) 1998-12-02
EE9800451A (en) 1999-06-15
ZA976331B (en) 1999-01-25
EP0880524B1 (en) 2000-04-19
BR9710747A (en) 1999-08-17
NO983860L (en) 1998-10-21
PL328824A1 (en) 1999-02-15
JP2000501420A (en) 2000-02-08
NO983860D0 (en) 1998-08-21
EP0978517A2 (en) 2000-02-09
ID19106A (en) 1998-06-18
CZ265498A3 (en) 1998-12-16
JP3020281B2 (en) 2000-03-15
WO1998003511A1 (en) 1998-01-29
BG102707A (en) 1999-09-30
HRP970395A2 (en) 1998-08-31
SK114498A3 (en) 1999-02-11
AU3695597A (en) 1998-02-10
DE19629378A1 (en) 1998-01-29
GR3033842T3 (en) 2000-10-31

Similar Documents

Publication Publication Date Title
DK0966454T3 (en) Disubstituted bicyclic heterocycles, their preparation and their use as drugs
NO991815D0 (en) Oxadiazoles, processes for their preparation and their use as drugs
NO993003L (en) Sulfonamide derivatives, processes for their preparation and their use as medicaments
DK0740668T3 (en) Tetracyclic derivatives, processes for their preparation and their use
DK0676409T3 (en) Erythromycin derivatives, processes for their preparation and their use as pharmaceuticals
DK1095025T3 (en) Benzimidazoles, their preparation and their use as drugs
DK1083171T3 (en) Pyrazoline derivatives, their preparation and use as drugs
NO20005146D0 (en) Thienylazolylalkoxyethanamines, their preparation and their use as drugs
DK1202733T3 (en) 3 (5) -amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
NO20001409L (en) Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions
NO963506D0 (en) 4-Heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents
NO20011503D0 (en) Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, their preparation and use as anorectic drugs
NO20006138D0 (en) Substituted indolinones, preparation and use thereof as drugs
IS2076B (en) Acyl-piperazinil-pyrimidine derivatives, their preparation and use as pharmaceuticals
DK0770059T3 (en) Substituted benzamidines, their preparation and their use as drugs
NO981522L (en) Amino acid derivatives, their preparation and use as endothelin antagonists
DK0912509T3 (en) Distamycin derivatives, processes for their preparation and their use as antitumor and antiviral agents
DK0903339T3 (en) Biphenylsulfonyl cyanamide, process for their preparation and their use as a drug
DK0880524T3 (en) Adenosine antagonists, processes for their preparation and their use as drugs
DK1015433T3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for their preparation and their use as drugs
DK1098891T3 (en) Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as drugs
NO960272D0 (en) Oxathiolanes, processes for their preparation and pharmaceutical compositions containing the same
DK0727416T3 (en) Substituted benzenesulfonylureas and thioureas, and process for their preparation, their use as
NO308213B1 (en) Substituted indanylidinacetylguanidines, their use and drugs containing the compounds
DK1086077T3 (en) New antiestrogens, methods for their preparation and their pharmaceutical use